Delivery Order SPE2DB24D1205-SPE2DB24FCUUH

Award Date 9/17/24
Potential Completion Date 10/8/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $12,960.30 firm-fixed-price contract is for the supply of 30-count unit dose capsules of the drug VYNDAMAX 61 MG. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical for providing a comprehensive range of medical commodities to support...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,602.01 firm fixed-price contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This delivery order is part of AmerisourceBergen's IDC with DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive range of...
This is a $26,816.48 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication, with a completion date of April 14, 2025. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 IDC with DLA Troop...
This is a firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of December 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The ceiling value of the delivery order is $12,960.30, and it has a firm fixed price pricing type. The period of performance runs from the award date of September 10, 2024, through October 1, 2024. This delivery order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a ceiling value of $25,920.62 and an ultimate completion date of September 4, 2024. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide the required medication to support the healthcare needs of...
This $12,960.30 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. The award has an ultimate completion date of September 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for providing pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,846.97 firm fixed-price contract is for the delivery of the drug VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. It is a firm fixed-price contract with a completion date of November 27, 2024. The contract is not associated with a set-aside program and appears to be an open competition award. AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a ceiling value of $12,960.30 and an ultimate completion date of October 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUUH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,960.30 firm fixed price contract is for the supply of the prescription drug VYNDAMAX 61 MG CAPSULE UD 30S. The contract has an ultimate completion date of October 8, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare facilities worldwide. The contract does not have a set-aside designation.

Generated 12/17/24, 9:17 AM